Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral Therapy

NACompletedINTERVENTIONAL
Enrollment

704

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Chronic HIV Infection
Interventions
DIAGNOSTIC_TEST

POC VL and targeted DRM testing.

Point-of-care Viral Load Testing will be done to ensure that providers and caregivers receive the results with in 24 hours study. Targeted DRM testing will be performed during the initiation of ART and when viremia (VL\>1000 copies/mL) is detected.

DIAGNOSTIC_TEST

SOC VL testing

SOC VL testing is done at 6 months after ART initiation then every 3 months if unsuppressed, otherwise every 12 months. DRM testing is conducted only if failing 2nd line ART.

Trial Locations (1)

Unknown

Rtcp-Faces, Kisumu

Sponsors
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Kenya Medical Research Institute

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Washington

OTHER

lead

University of Alabama at Birmingham

OTHER